3 Stocks Estimated To Be Trading Below Their Intrinsic Value

In This Article:

In the current global market landscape, uncertainty surrounding the incoming Trump administration's policies has led to volatility across various sectors, with financials and energy benefiting from deregulation hopes while healthcare faces challenges due to potential policy shifts. Amidst these fluctuations, identifying stocks trading below their intrinsic value can offer investors opportunities for growth by focusing on companies with strong fundamentals that may be temporarily undervalued by the market.

Top 10 Undervalued Stocks Based On Cash Flows

Name

Current Price

Fair Value (Est)

Discount (Est)

Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016)

CN¥16.71

CN¥33.16

49.6%

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211)

CN¥38.49

CN¥76.93

50%

Taiwan Union Technology (TPEX:6274)

NT$156.50

NT$311.70

49.8%

Wuhan Keqian BiologyLtd (SHSE:688526)

CN¥14.57

CN¥29.09

49.9%

ConvaTec Group (LSE:CTEC)

£2.43

£4.85

49.9%

TF Bank (OM:TFBANK)

SEK312.00

SEK621.04

49.8%

AirBoss of America (TSX:BOS)

CA$4.23

CA$8.44

49.9%

Saipem (BIT:SPM)

€2.342

€4.65

49.6%

Intellian Technologies (KOSDAQ:A189300)

₩44450.00

₩88893.31

50%

Nokian Renkaat Oyj (HLSE:TYRES)

€7.408

€14.72

49.7%

Click here to see the full list of 935 stocks from our Undervalued Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool.

Kempower Oyj

Overview: Kempower Oyj manufactures and sells electric vehicle charging equipment and solutions under the Kempower brand in the Nordics, Europe, North America, and internationally, with a market cap of €547.49 million.

Operations: Kempower Oyj's revenue is primarily derived from its electric equipment segment, totaling €234.81 million.

Estimated Discount To Fair Value: 30.7%

Kempower Oyj is trading at €9.91, significantly below its estimated fair value of €14.29, indicating potential undervaluation based on discounted cash flow analysis. Despite recent volatility and lowered revenue guidance for 2024, Kempower's earnings are projected to grow by 72.04% annually, with profitability expected within three years—surpassing average market growth rates. The appointment of Mathias Wiklund as CSO may bolster sales efforts amid these financial challenges and opportunities for growth.

HLSE:KEMPOWR Discounted Cash Flow as at Nov 2024
HLSE:KEMPOWR Discounted Cash Flow as at Nov 2024

Ningbo Sanxing Medical ElectricLtd

Overview: Ningbo Sanxing Medical Electric Co., Ltd. manufactures and sells power distribution and utilization systems both in China and internationally, with a market capitalization of CN¥46.02 billion.